Rice Hall James & Associates, LLC Collegium Pharmaceutical, Inc Transaction History

Rice Hall James & Associates, LLC

$1.69 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$14.22 - $20.88 $2.28 Million - $3.35 Million	-160,353 Reduced 36.68%	276,847 $4.91 Million
Q1 2022 May 05, 2022	SELL	$17.2 - $22.5 $4.59 Million - $6.01 Million	-267,001 Reduced 37.92%	437,200 $8.9 Million
Q4 2021 Feb 14, 2022	SELL	$17.5 - $21.35 $854,647 - $1.04 Million	-48,837 Reduced 6.49%	704,201 $13.2 Million
Q3 2021 Nov 09, 2021	SELL	$17.75 - $25.39 $821,115 - $1.17 Million	-46,260 Reduced 5.79%	753,038 $14.9 Million
Q2 2021 Jul 29, 2021	SELL	$21.74 - $25.28 $2.75 Million - $3.2 Million	-126,530 Reduced 13.67%	799,298 $18.9 Million
Q1 2021 May 14, 2021	BUY	$19.25 - $26.1 $94,382 - $127,968	4,903 Added 0.53%	925,828 $21.9 Million
Q4 2020 Feb 16, 2021	SELL	$17.83 - $22.29 $3.34 Million - $4.17 Million	-187,294 Reduced 16.9%	920,925 $18.4 Million
Q3 2020 Nov 16, 2020	BUY	$15.78 - $20.82 $1.76 Million - $2.32 Million	111,601 Added 11.2%	1,108,219 $23.1 Million
Q2 2020 Aug 14, 2020	SELL	$15.49 - $23.51 $576,274 - $874,642	-37,203 Reduced 3.6%	996,618 $17.4 Million
Q1 2020 May 15, 2020	SELL	$13.89 - $25.45 $313,427 - $574,279	-22,565 Reduced 2.14%	1,033,821 $16.9 Million
Q4 2019 Jan 29, 2020	SELL	$10.7 - $22.24 $1.7 Million - $3.54 Million	-159,243 Reduced 13.1%	1,056,386 $21.7 Million
Q3 2019 Oct 30, 2019	SELL	$10.16 - $13.28 $457,819 - $598,410	-45,061 Reduced 3.57%	1,215,629 $14 Million
Q2 2019 Aug 01, 2019	BUY	$10.62 - $16.59 $738,610 - $1.15 Million	69,549 Added 5.84%	1,260,690 $16.6 Million
Q1 2019 May 01, 2019	BUY	$13.58 - $18.72 $3.52 Million - $4.85 Million	259,015 Added 27.79%	1,191,141 $18 Million
Q4 2018 Feb 14, 2019	BUY	$14.78 - $19.68 $5.41 Million - $7.21 Million	366,184 Added 64.7%	932,126 $16 Million
Q3 2018 Oct 25, 2018	BUY	$14.16 - $24.3 $1.83 Million - $3.15 Million	129,432 Added 29.65%	565,942 $8.34 Million
Q2 2018 Aug 02, 2018	BUY	$21.79 - $28.29 $1.17 Million - $1.51 Million	53,530 Added 13.98%	436,510 $10.4 Million
Q1 2018 Apr 25, 2018	BUY	$18.15 - $29.21 $914,632 - $1.47 Million	50,393 Added 15.15%	382,980 $9.79 Million
Q4 2017 Jan 23, 2018	BUY	$9.3 - $19.14 $2.57 Million - $5.28 Million	276,123 Added 489.02%	332,587 $6.14 Million
Q3 2017 Oct 30, 2017	BUY	$9.15 - $11.97 $516,645 - $675,874	56,464	56,464 $592,000

Others Institutions Holding COLL

# of Institutions

254

Shares Held

36.9M

Call Options Held

100K

Put Options Held

21.1K

Black Rock Inc. New York, NY

5.79M
Shares

$191 Million
0.0% of portfolio
Eventide Asset Management, LLC Boston, MA

2.64M
Shares

$86.7 Million
1.79% of portfolio
Pacer Advisors, Inc. Malvern, PA

2.59M
Shares

$85.2 Million
0.24% of portfolio
Vanguard Group Inc Valley Forge, PA

2.35M
Shares

$77.2 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.66M
Shares

$54.5 Million
0.1% of portfolio

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.12B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rice Hall James & Associates, LLC with notifications on news.

Account